Rankings
▼
Calendar
SLNO FY 2017 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SLNO
Soleno Therapeutics, Inc.
$2B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
-$1.6B
-107145.4% YoY
Gross Profit
-$1.6B
100.1% margin
Operating Income
-$12M
0.8% margin
Net Income
-$16M
1.0% margin
EPS (Diluted)
$-26.18
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$880,031
Balance Sheet
Total Assets
$39M
Total Liabilities
$12M
Stockholders' Equity
$27M
Cash & Equivalents
$17M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
-$1.6B
$1M
-107145.4%
Gross Profit
-$1.6B
-$58,518
-2656540.7%
Operating Income
-$12M
-$14M
+10.6%
Net Income
-$16M
-$12M
-29.9%
← Q4 2016
All Quarters
Q1 2017 →